US launches clinical trial of stem cell therapy

Clinical trial of human embryonic stem cells was started at a hospital in Georgia, USA. Biotech company Geron said it was licensed by the US government to use this controversial method to treat patients.

This trial is aimed at treating people with severe spinal injuries. ' This is an important test in the field of human embryonic stem cell therapy, ' said Thomas Okarma, President and CEO of Geron.

Human embryonic stem cells are a versatile cell that can grow in any cell in the body. However, the controversial cause in this research program is that scientists must destroy human embryos to obtain stem cells.

Stem cells from human embryos (Photo: Reuters)

' Patients treated at the center have recovered spinal function ' - said Geron. As soon as this information was released on Monday afternoon on October 11, Geron's shares rose 6.4%.

Earlier, the White House spokesman insisted that the government would resist the law against government funding for the destruction of human embryos, the origin of stem cells, because these studies are fertile. death with human life.